Furthermore, acetylcholinesterase (AChE) inhibitors, which have been successfully used in animal models to activate the cholinergic anti-inflammatory pathway, are widely used in the clinic to treat Alzheimer’s disease (AD) (23–26). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.